Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
5266 participants
INTERVENTIONAL
2020-10-13
2020-10-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Email
The "standard of care" email is the same as one used in prior outreach efforts at the health system, emphasizing reduced cost for medications and convenience.
Highlighting Cost Savings and Convenience
Email with Healthcare Cost Savings
The email emphasizes future reductions in healthcare costs due to increased adherence with mail-order pharmacy, in addition to mentioning reduced prices for medications. It also uses fear appeals by stating the risk of hospital stays and how mail-order pharmacy could be an easily-achievable way to avoid this negative consequence.
Fear Appeals
Message about Future Healthcare Costs
Highlighting Cost Savings and Convenience
Email with Endorsement
The email is a letter from a doctor at the health system's health plan--who may been seen as a trusted source of information--encouraging the benefits of using a mail-order pharmacy.
Endorsement from a Doctor
Highlighting Cost Savings and Convenience
Email with Comparison Table
The email includes a table comparing the benefits and drawbacks of mail-order and chain pharmacies, which appeals to their sense of agency and allows them to make the choice that best suits them.
Comparison Table
Highlighting Cost Savings and Convenience
No Contact
Members do not receive an email.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fear Appeals
Message about Future Healthcare Costs
Endorsement from a Doctor
Comparison Table
Highlighting Cost Savings and Convenience
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Currently prescribed maintenance medications
* Not currently subscribed to the health system's mail-order pharmacy
* Has an email on record
Exclusion Criteria
* Only has eligible current prescriptions for fewer than 28 days
* Only has prescriptions that cannot be sent via mail-order pharmacy (e.g., antidepressants, specialty-tier drugs)
* Is a Medicare member in the coverage gap
* Shares an email address with another selected participant (who was randomly chosen for inclusion among all those sharing the same email address)
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Geisinger Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amir Goren
Program Director, Behavioral Insights Team
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Amir Goren, PhD
Role: PRINCIPAL_INVESTIGATOR
Geisinger Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Geisinger
Danville, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-0482
Identifier Type: -
Identifier Source: org_study_id